Baron Tomasz, Bergsten Johannes, Albåge Anders, Lundin Lennart, Sörensen Jens, Öberg Kjell, Flachskampf Frank A
Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Cardiology, and Clinical Physiology, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Cardiology, and Clinical Physiology, Uppsala University, Uppsala, Sweden.
JACC Cardiovasc Imaging. 2021 Nov;14(11):2240-2253. doi: 10.1016/j.jcmg.2020.12.030. Epub 2021 Apr 14.
Carcinoid disease is caused by neuroendocrine tumors, most often located in the gut, and leads in approximately 20% of cases to specific, severe heart disease, most prominently affecting right-sided valves. If cardiac disease occurs, it determines the patient's prognosis more than local growth of the tumor. Surgical treatment of carcinoid-induced valve disease has been found to improve survival in observational studies. Cardiac imaging is crucial for both diagnosis and management of carcinoid heart disease; in the past, imaging was accomplished largely by echocardiography, but more recently, imaging for carcinoid heart disease has increasingly become multimodal and warrants awareness of the particular diagnostic challenges of this disease. This paper reviews the pathophysiology and manifestations of carcinoid heart disease in light of the different imaging modalities.
类癌病由神经内分泌肿瘤引起,这些肿瘤大多位于肠道,约20%的病例会导致特定的严重心脏病,最显著的是影响右侧瓣膜。如果发生心脏病,它对患者预后的影响比肿瘤的局部生长更大。在观察性研究中发现,手术治疗类癌引起的瓣膜病可提高生存率。心脏成像对于类癌心脏病的诊断和管理都至关重要;过去,成像主要通过超声心动图完成,但最近,类癌心脏病的成像越来越多地采用多模态,需要认识到这种疾病特殊的诊断挑战。本文根据不同的成像方式综述类癌心脏病的病理生理学和表现。